Kirn David Insider Trades

Insider Trading History

Track insider trading activity for Kirn David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $7.15M 750,000 shares
Last Trade
Mar 25, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.41M 750,000 shares
$9.88
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $2.55M 267,500 shares
Last Trade
Mar 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.11M 267,500 shares
$4.14
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $10.2M 1,072,076 shares
Last Trade
Jul 10, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$300k 12,923 shares
$23.21
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $5.39M 565,417 shares
Last Trade
Jul 10, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$300k 12,923 shares
$23.21
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $10.1M 1,059,153 shares
Last Trade
Jul 10, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$291k 12,923 shares
$22.49
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $5.5M 577,070 shares
Last Trade
Jun 24, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$301k 12,930 shares
$23.25
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $10.2M 1,072,083 shares
Last Trade
Jun 24, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$301k 12,930 shares
$23.25
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $10.1M 1,059,153 shares
Last Trade
Jun 24, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$299k 12,930 shares
$23.10
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $10.1M 1,059,153 shares
Last Trade
Feb 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.5M 92,001 shares
$27.13
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $11M 1,151,154 shares
Last Trade
Jan 23, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$105k 5,696 shares
$18.41
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $11M 1,156,983 shares
Last Trade
Jan 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$552k 28,237 shares
$19.56
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $11.3M 1,185,087 shares
Last Trade
Jan 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$827k 40,732 shares
$20.31
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $11.7M 1,225,819 shares
Last Trade
Dec 18, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$85.2k 4,702 shares
$18.13
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $11.7M 1,230,521 shares
Last Trade
Dec 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$494k 28,632 shares
$17.27
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $5.62M 590,000 shares
Last Trade
Dec 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.51M 590,000 shares
$14.42
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $12M 1,259,153 shares
Last Trade
May 02, 2023 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$11.3M 600,000 shares
$18.86
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $5.72M 600,000 shares
Last Trade
May 02, 2023 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$11.3M 600,000 shares
$18.86
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $17.7M 1,859,153 shares
Last Trade
Feb 22, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$333k 16,449 shares
$20.22
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $17.9M 1,876,509 shares
Last Trade
Feb 21, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$377k 17,997 shares
$20.96
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Chief Executive Officer
Holding Value $2.12M 222,000 shares
Last Trade
Feb 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.49M 222,000 shares
$20.24
$9.53

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up